{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:38:48Z","timestamp":1767937128203,"version":"3.49.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hematoma, seroma, and unplanned reoperation are the most frequent early complications after gender-affirming mastectomy with hematoma being the most common complication and the most common reason for reoperation. Tranexamic acid (TXA) is increasingly incorporated into enhanced-recovery protocols, yet its route-specific benefits remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, databases were searched for comparative studies of TXA versus no TXA in transmasculine chest surgery. Review Manager 5.4 was used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Seven retrospective cohorts (2534 patients) met the inclusion criteria. Overall, TXA significantly reduced hematoma risk by 41% (relative risk reduction [RRR] = 41%; risk ratio [RR] = 0.59, 95% confidence interval: 0.41\u20130.83;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.003;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      \u00b2 = 3%). Subgroup analysis for route of administration demonstrated that the benefit was confined to intravenous (IV) TXA (RR 0.49, 0.25\u20130.95), not topical (RR 0.74, 0.43\u20131.26). Unplanned returns to the operating room fell by 62% with IV TXA (RRR = 62%; RR = 0.38, 0.23\u20130.64). The overall effect on seroma was nonsignificant (RR 0.89, 0.59\u20131.36), but subgroup analysis showed that IV TXA lowered seroma risk by 33% (RRR = 33%; RR 0.67, 0.51\u20130.88;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.004); topical TXA showed no benefit. Pooled analysis for infection was not significant (RR 0.77, 0.34\u20131.73); IV TXA halved infections (RR 0.38, 0.15\u20130.95), whereas topical TXA did not. Nipple\u2013areola necrosis and wound-healing complications were unaffected. TXA did not increase thromboembolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IV TXA safely reduces risks of hematoma, seroma, and reoperation after gender-affirming mastectomy, without increasing venous thromboembolism risk. Topical TXA confers no measurable advantage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/gox.0000000000007352","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:00:10Z","timestamp":1766070010000},"page":"e7352","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bleeding, Drains, and Reoperation in Transmasculine Chest Surgery: What 2,534 Patients Tell Us About Tranexamic Acid"],"prefix":"10.1097","volume":"13","author":[{"given":"Nina","family":"Pollack","sequence":"first","affiliation":[{"name":"Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Tanas","sequence":"additional","affiliation":[{"name":"Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarya","family":"Swed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Aleppo, Aleppo, Syria"},{"name":"Department of Public Health and Preventive Medicine, Damascus University, Damascus, Syria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Padilla","sequence":"additional","affiliation":[{"name":"Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bjps.2023.09.002","article-title":"Impact of surgical technique on outcome measures in chest masculinization: a systemic review and meta-analysis.","volume":"87","author":"Zhu","year":"2023","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/SAP.0000000000001354","article-title":"Masculinizing top surgery.","volume":"80","author":"Wilson","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/XCS.0000000000000940","article-title":"Gender-affirming mastectomy: psychosocial and surgical outcomes in transgender adults.","volume":"238","author":"Bertrand","year":"2024","journal-title":"J Am Coll Surg"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjsurg.2021.12.032","article-title":"Masculinizing chest surgery for gender affirmation: a retrospective study of outcomes and patient reported satisfaction.","volume":"223","author":"Kelly-Schuette","year":"2022","journal-title":"Am J Surg"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/PRS.0000000000007997","article-title":"Tips and tricks in gender-affirming mastectomy.","volume":"147","author":"Salibian","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ALN.0000000000000463","article-title":"Practice guidelines for perioperative blood management.","volume":"122","year":"2015","journal-title":"Anesthesiology"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid.","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"887386","DOI":"10.3389\/fphar.2022.887386","article-title":"Does tranexamic acid reduce the blood loss in various surgeries? An umbrella review of state-of-the-art meta-analysis.","volume":"13","author":"Hong","year":"2022","journal-title":"Front Pharmacol"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/SLA.0000000000003793","article-title":"A single preoperative dose of tranexamic acid reduces perioperative blood loss.","volume":"273","author":"Heyns","year":"2021","journal-title":"Ann Surg"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1097\/SAP.0000000000003296","article-title":"The usage of intravenous tranexamic acid in reduction mammaplasty safely reduces hematoma rates.","volume":"90","author":"Om","year":"2023","journal-title":"Ann Plast Surg"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1097\/MS9.0000000000001224","article-title":"Tranexamic acid in rhytidectomy: a scoping review.","volume":"85","author":"Soltany","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"e6275","DOI":"10.1097\/GOX.0000000000006275","article-title":"Tranexamic acid in rhinoplasty and septoplasty: a systematic review and meta-analysis of randomized controlled trials.","volume":"12","author":"Khajuria","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bjps.2025.01.048","article-title":"Efficacy of topical tranexamic acid in gender-affirming mastectomy.","volume":"102","author":"Falade","year":"2025","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00266-024-04389-0","article-title":"Comparative outcomes of superomedial and inferior pedicles in breast reduction and mastopexy: a meta-analysis of 5123 breasts.","volume":"49","author":"Tanas","year":"2025","journal-title":"Aesthetic Plast Surg"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"ojaf084","DOI":"10.1093\/asjof\/ojaf084","article-title":"AlloDerm versus DermACELL in breast reconstruction: a systematic review and meta-analysis of all head-to-head comparisons.","volume":"7","author":"Tanas","year":"2025","journal-title":"Aesthet Surg J Open Forum"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"e6206","DOI":"10.1097\/GOX.0000000000006206","article-title":"A meta-analysis comparing deep inferior epigastric perforator flaps and latissimus dorsi flaps in breast reconstruction.","volume":"12","author":"Tanas","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.3390\/jcm12227083","article-title":"Implementation of an enhanced recovery after surgery pathway for transgender and gender-diverse individuals undergoing chest reconstruction surgery: an observational cohort study.","volume":"12","author":"Aquino","year":"2023","journal-title":"J Clin Med"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bjps.2023.11.027","article-title":"Outcomes of enhanced recovery protocols and tranexamic acid on double-incision versus periareolar gender-affirming mastectomy: a retrospective study of postoperative outcomes.","volume":"88","author":"Edalatpour","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"1002e","DOI":"10.1097\/PRS.0000000000010892","article-title":"Use of tranexamic acid in gender-affirming mastectomy reduces rates of postoperative hematoma and seroma.","volume":"153","author":"Rifkin","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpra.2025.01.002","article-title":"Topical tranexamic acid and chest masculinization surgeries\u2014impact on postoperative hematoma incidence.","volume":"43","author":"Sipos","year":"2025","journal-title":"JPRAS Open"},{"key":"R23-20260108","first-page":"501","article-title":"Topical application of tranexamic acid in subcutaneous mastectomy wounds in female-to-male transgender patients.","volume":"54","author":"Keck","year":"2022","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bjps.2017.09.003","article-title":"Subcutaneous mastectomy in female-to-male transsexuals: optimizing perioperative and operative management in 8 years clinical experience.","volume":"71","author":"Wolter","year":"2018","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R25-20260108","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/S0140-6736(16)30697-3","article-title":"Utako Okamoto.","volume":"387","author":"Watts","year":"2016","journal-title":"Lancet"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"key":"R28-20260108","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.","volume":"394","author":"Roberts","year":"2019","journal-title":"Lancet"},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/ALN.0b013e318210f9e3","article-title":"Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study.","volume":"114","author":"Dadure","year":"2011","journal-title":"Anesthesiology"},{"key":"R30-20260108","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jcms.2015.05.004","article-title":"The value of tranexamic acid during fronto-orbital advancement in isolated metopic craniosynostosis.","volume":"43","author":"Engel","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PRS.0000000000003926","article-title":"The role of tranexamic acid in plastic surgery: review and technical considerations.","volume":"141","author":"Rohrich","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"R32-20260108","doi-asserted-by":"crossref","DOI":"10.1007\/s00266-025-05052-y","article-title":"Utility of tranexamic acid in reduction mammaplasty: a systematic review and meta-analysis.","author":"Fung","year":"2025","journal-title":"Aesthetic Plast Surg"},{"key":"R33-20260108","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PRS.0000000000010952","article-title":"Topical tranexamic acid does not reduce hematoma in reduction mammaplasty: a double-blind randomized controlled trial.","volume":"154","author":"Yao","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid\u2013associated seizures: causes and treatment.","volume":"79","author":"Lecker","year":"2015","journal-title":"Ann Neurol"}],"container-title":["Plastic and Reconstructive Surgery - Global Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:00:14Z","timestamp":1767913214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/gox.0000000000007352","relation":{},"ISSN":["2169-7574"],"issn-type":[{"value":"2169-7574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}